Elanco Animal Health to Engage Investors in Upcoming Conferences

Elanco Animal Health Incorporated, traded on the New York Stock Exchange under the symbol ELAN, recently announced its participation in notable investor conferences that will showcase the company’s strategic vision and future outlook. These important engagements are scheduled for late May and early June, offering stakeholders a chance to gain insights directly from the company's leadership.

Upcoming Events

On May 27, 2026, Elanco's President and CEO, Jeff Simmons, along with CFO Bob VanHimbergen, will participate in a fireside chat at the Stifel 2026 Jaws Paws Conference. This event is planned for 8:00 AM ET, where they will discuss Elanco's innovative approach to animal health and animal welfare, reaffirming the company's commitment to advancing the industry's standards.

Following this, on June 2, Jeff Simmons will address attendees at the William Blair 46th Annual Growth Stock Conference at 3:20 PM CT. During this presentation, he is expected to elaborate on the company's recent achievements and strategic directions aimed at enhancing animal health and welfare.

Webcast Information

Both events will be available via live audio webcasts, which can be accessed in the Events and Presentations section of Elanco's investor relations website. For those unable to attend live, replays of the webcasts will be accessible for a limited duration post-event, ensuring that all interested stakeholders can stay informed about the developments at Elanco.

About Elanco

Elanco Animal Health is recognized globally as a pioneer in the field of animal health, delivering innovative products and services designed to prevent and treat diseases in both farm animals and pets. With a proud heritage that spans more than 70 years, Elanco is dedicated to providing value to farmers, pet owners, veterinarians, and society at large.

The company is operated with a clear vision: Food and Companionship Enriching Life, supported by its purpose to go beyond mere product provision for animals and create sustainable practices that benefit customers, society, and the community. Elanco’s commitment to health and well-being reflects its robust portfolio of products aimed at improving the health of animals around the world while fostering safe and healthy environments for both animals and humans.

Final Thoughts

The upcoming investor conferences are an excellent opportunity for stakeholders to engage with Elanco's management, gaining insights into the company’s innovative practices and commitment to animal health. With an unwavering focus on advancing healthcare solutions for animals, Elanco continues to break boundaries and advocate for a positive and sustainable impact on community health and well-being.

For additional information about Elanco’s participation in these events and to learn more about their innovative products and services, visit their official website.